Skip to main content

Advertisement

Table 1 Summary of meta-regression analysis using dosage and duration as covariates on appropriate cardiometabolic biomarkers (i.e. ≥ 10 RCTs)

From: Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials

Moderator variable p value Meta-regression of moderator variable vs. effect size
Low density lipoprotein
 Duration 0.85 Slope 0.00, 95% CI − 0.01 to 0.01, df = 27
 Dosage 0.14 Slope 0.03, 95% CI − 0.01 to 0.07, df = 27
Triglycerides
 Duration 0.35 Slope 0.01, 95% CI − 0.01 to 0.01, df = 31
 Dosage 0.87 Slope -0.00, 95% CI − 0.07 to 0.08, df = 31
Glycated haemoglobin
 Duration 0.11 Slope 0.01, 95% CI − 0.00 to 0.02, df = 32
 Dosage 0.55 Slope 0.03, 95% CI − 0.07 to 0.13, df = 32